PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-03-22

Date Title Company
22-Mar-2019 Applied LifeSciences & Systems Announces Closing of its $8 Million Series A Round of Equity Financing Applied LifeSciences & Systems
22-Mar-2019 Global Bioenergies greets the French parliament's proposal aiming to promote a French bio-jet fuel industry Global Bioenergies
22-Mar-2019 Positive FDA Meeting Outlines Path Ahead for Akari Therapeutics’s Coversin in Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) Akari Therapeutics
22-Mar-2019 Ortho Clinical Diagnostics' VITROS® XT MicroSlide Receives CE Mark: First Multi-test Capability Added to Proprietary MicroSlide Technology Ortho Clinical Diagnostics
22-Mar-2019 Orion Biotechnology Canada Announces Three New Appointments to Their Senior Management Team Orion Biotechnology
22-Mar-2019 Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease Aldevron
22-Mar-2019 Insilico Medicine partners with Master Investor Insilico Medicine
22-Mar-2019 CIC makes investment in Gyroscope Therapeutics Cambridge Innovation Capital
22-Mar-2019 AstraZeneca to present new cardiovascular data on Farxiga in type-2 diabetes at ACC 2019 AstraZeneca
22-Mar-2019 FDA approves Neurolixis IND application for clinical trial with NLX-112 in Parkinson’s Neurolixis
22-Mar-2019 Ireland to lead €7 million Parkinson’s research project RCSI
22-Mar-2019 Helsinn initiates two new global Phase III studies with anamorelin Helsinn
22-Mar-2019 Akili and Shionogi Announce Strategic Partnership to Develop and Commercialise Digital Therapeutics in Key Asian Markets Akili Interactive
22-Mar-2019 NEW PHASE 3 STELARA® (USTEKINUMAB) DATA SHOW POSITIVE RESULTS AS MAINTENANCE THERAPY IN ADULTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS Janssen Pharmaceutical
22-Mar-2019 Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies Biocartis
22-Mar-2019 Santhera Completes Patient Enrollment in Phase IV Long-term Study with Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy Santhera Pharmaceuticals
22-Mar-2019 PredictImmune announce formal entry of PredictSURE IBD™ into the NICE Diagnostic Assessment Programme PredictImmune
22-Mar-2019 Pharmaoffer, a Pharma Tech Start-up is Fighting Global Medicine Shortage Pharmaoffer
22-Mar-2019 PULS changes its name to AQILION AB PULS
22-Mar-2019 Researchers hunt for sustainable alternatives to shark compound used in vaccines The University of Nottingham